You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mucosal melanoma

Showing 1 - 25 of 4,041
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Mucosal Melanoma Trial (Envafolimab combined with recombinant human endostatin and first-line chemo)

Not yet recruiting
  • Advanced Mucosal Melanoma
  • Envafolimab combined with recombinant human endostatin and first-line chemotherapy
  • (no location specified)
Sep 15, 2023

Mucosal Melanoma Trial in Wollstonecraft (Pembrolizumab, Lenvatinib)

Not yet recruiting
  • Mucosal Melanoma
  • Wollstonecraft, New South Wales, Australia
    Melanoma Institute Australia
Sep 15, 2022

Melanoma Trial in Beijing City, Fuzhou City, Zhejiang (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Melanoma
  • Beijing City, China
  • +2 more
Dec 13, 2022

Mucosal Melanoma Trial in New York (Nivolumab and/or Ipilimumab, Stereotactic Body Radiation Therapy (SBRT), axitinib)

Recruiting
  • Mucosal Melanoma
  • Nivolumab and/or Ipilimumab
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 14, 2022

Acral Melanoma, Mucosal Melanoma Trial in Seoul (Pembrolizumab, Vactosertib)

Not yet recruiting
  • Acral Melanoma
  • Mucosal Melanoma
  • Pembrolizumab, Vactosertib
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jun 23, 2022

Mucosal Melanoma of the Head and Neck Trial in Saint Louis (Pembrolizumab, Hypofractionated radiation therapy)

Recruiting
  • Mucosal Melanoma of the Head and Neck
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 7, 2022

Mucosal Melanoma Trial in China (YH003, Pembrolizumab, albumin paclitaxel)

Recruiting
  • Mucosal Melanoma
  • Fuzhou, Fujian, China
  • +11 more
Oct 8, 2022

Anal Melanoma, Bladder Melanoma, Cervical Melanoma Trial in United States (Cabozantinib S-malate, Nivolumab, Placebo

Recruiting
  • Anal Melanoma
  • +18 more
  • Cabozantinib S-malate
  • +5 more
  • Los Angeles, California
  • +53 more
Jan 31, 2023

Malignant Melanoma Trial in Aurora (Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab)

Recruiting
  • Malignant Melanoma
  • Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab
  • Aurora, Colorado
    University of Colorado Hospital
May 25, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

Recruiting
  • Metastatic Melanoma
  • +9 more
  • TBio-4101
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)

Not yet recruiting
  • Recurrent Metastatic Melanoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Jul 29, 2022

Melanoma, Melanoma (Skin), Moles Trial in Nizhny Novgorod, Moscow (Non-invasive adhesive system (patch))

Recruiting
  • Melanoma
  • +11 more
  • Non-invasive adhesive system (patch)
  • Nizhny Novgorod, Russian Federation
  • +1 more
Jun 12, 2022

Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV Trial in Iowa City, Rochester, Madison ([212Pb]VMT01)

Not yet recruiting
  • Melanoma (Skin)
  • +5 more
  • Iowa City, Iowa
  • +2 more
Dec 8, 2022

Malignant Melanoma, Sinonasal Melanoma Trial in Shanghai (endoscopic surgery)

Recruiting
  • Malignant Melanoma
  • Sinonasal Melanoma
  • endoscopic surgery
  • Shanghai, Shanghai, China
    Eye& ENT Hospital, Fudan University
May 8, 2022

Cutaneous Melanoma, Mucosal Melanoma Trial in Worldwide (Nemvaleukin Alfa Subcutaneous, Nemvaleukin Alfa Intravenous)

Recruiting
  • Cutaneous Melanoma
  • Mucosal Melanoma
  • Nemvaleukin Alfa Subcutaneous
  • Nemvaleukin Alfa Intravenous
  • La Jolla, California
  • +26 more
Aug 1, 2022

Metastatic Melanoma, Stage III Mucosal Melanoma of the Head and Neck, Stage IIIA Skin Melanoma Trial in New Brunswick

Active, not recruiting
  • Metastatic Melanoma
  • +8 more
  • Aldesleukin
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 20, 2021

Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Tumor in the Brain Trial in

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +6 more
  • Ipilimumab
  • +4 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Dec 12, 2022

Head and Neck Mucosal Melanomas Trial in Villejuif (drug, procedure, radiation)

Recruiting
  • Head and Neck Mucosal Melanomas
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jul 21, 2021

Acral Lentiginous Melanoma, CNS Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Houston (Nivolumab)

Active, not recruiting
  • Acral Lentiginous Melanoma
  • +9 more
  • Biospecimen Collection
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2023

Melanoma Trial in Changchun (Camrelizumab, Anlotinib, nab-Paclitaxel)

Recruiting
  • Melanoma
  • Changchun, Jilin, China
    The first hospital of Jilin University
Jul 27, 2021

Melanoma (Skin), Melanoma Stage IV, Melanoma, Uveal Trial in Rochester ([203Pb]VMT01, [68Ga]VMT02)

Recruiting
  • Melanoma (Skin)
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Aug 5, 2022

Malignant Melanoma Trial in United Kingdom (PLX3397)

Completed
  • Malignant Melanoma
  • Manchester, Greater Manchester, United Kingdom
  • +7 more
Aug 11, 2021

Mucosal Melanoma, Sinonasal Melanoma Trial in Shanghai (procedure, radiation, drug)

Recruiting
  • Mucosal Melanoma
  • Sinonasal Melanoma
  • endoscopic surgery
  • +2 more
  • Shanghai, Shanghai, China
    Eye& ENT Hospital, Fudan University
Aug 16, 2021

Melanoma Trial (Nivolumab, Radiation Therapy)

Withdrawn
  • Melanoma
  • (no location specified)
Feb 14, 2021